
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1836 | -61.7142857143 | 0.2975 | 0.315764 | 0.1139 | 7104003 | 0.13453877 | CS |
4 | -0.2071 | -64.5171339564 | 0.321 | 0.347 | 0.1139 | 2010131 | 0.15269916 | CS |
12 | -0.2652 | -69.9551569507 | 0.3791 | 0.446 | 0.1139 | 903829 | 0.20754557 | CS |
26 | -0.4118 | -78.3336503709 | 0.5257 | 0.608 | 0.1139 | 727953 | 0.31531384 | CS |
52 | -0.5791 | -83.5642135642 | 0.693 | 0.87 | 0.1139 | 594264 | 0.41781932 | CS |
156 | -2.0161 | -94.6525821596 | 2.13 | 5.95 | 0.1139 | 490694 | 1.38812261 | CS |
260 | -16.8861 | -99.33 | 17 | 35.6 | 0.1139 | 567241 | 2.99674174 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관